Department of Pediatrics, University of California San Diego, La Jolla, CA, USA; Universität Leipzig, Klinik und Poliklinik für Kardiologie, Leipzig, Germany.
Department of Pediatrics, University of California San Diego, La Jolla, CA, USA.
J Hepatol. 2021 Jan;74(1):156-167. doi: 10.1016/j.jhep.2020.07.041. Epub 2020 Aug 4.
BACKGROUND & AIMS: Increased hepatocyte death contributes to the pathology of acute and chronic liver diseases. However, the role of hepatocyte pyroptosis and extracellular inflammasome release in liver disease is unknown.
We used primary mouse and human hepatocytes, hepatocyte-specific leucine 351 to proline Nlrp3CreA mice, and Gsdmd mice to investigate pyroptotic cell death in hepatocytes and its impact on liver inflammation and damage. Extracellular NOD-, LRR-, and pyrin domain-containing protein 3 (NLRP3) inflammasomes were isolated from mutant NLRP3-YFP HEK cells and internalisation was studied in LX2 and primary human hepatic stellate cells. We also examined a cohort of 154 adult patients with biopsy-proven non-alcoholic fatty liver disease (Sir Charles Gairdner Hospital, Nedlands, Western Australia).
We demonstrated that primary mouse and human hepatocytes can undergo pyroptosis upon NLRP3 inflammasome activation with subsequent release of NLRP3 inflammasome proteins that amplify and perpetuate inflammasome-driven fibrogenesis. Pyroptosis was inhibited by blocking caspase-1 and gasdermin D activation. The activated form of caspase-1 was detected in the livers and in serum from patients with non-alcoholic steatohepatitis and correlated with disease severity. Nlrp3CreA mice showed spontaneous liver fibrosis under normal chow diet, and increased sensitivity to liver damage and inflammation after treatment with low dose lipopolysaccharide. Mechanistically, hepatic stellate cells engulfed extracellular NLRP3 inflammasome particles leading to increased IL-1β secretion and α-smooth muscle actin expression. This effect was abrogated when cells were pre-treated with the endocytosis inhibitor cytochalasin B.
These results identify hepatocyte pyroptosis and release of inflammasome components as a novel mechanism to propagate liver injury and liver fibrosis development.
Our findings identify a novel mechanism of inflammation in the liver. Experiments in cell cultures, mice, and human samples show that a specific form of cell death, called pyroptosis, leads to the release of complex inflammatory particles, the NLRP3 inflammasome, from inside hepatocytes into the extracellular space. From there they are taken up by other cells and thereby mediate inflammatory and pro-fibrogenic stress signals. The discovery of this mechanism may lead to novel treatments for chronic liver diseases in the future.
肝细胞死亡增加导致急性和慢性肝病的病理变化。然而,肝细胞细胞焦亡和细胞外炎性小体释放在肝病中的作用尚不清楚。
我们使用原代小鼠和人肝细胞、肝特异性亮氨酸 351 至脯氨酸 Nlrp3CreA 小鼠和 Gsdmd 小鼠,研究了肝细胞细胞焦亡及其对肝炎症和损伤的影响。从突变型 NLRP3-YFP HEK 细胞中分离出细胞外 NOD、LRR 和吡喃结构域蛋白 3(NLRP3)炎性小体,并在 LX2 和原代人肝星状细胞中研究其内化情况。我们还检查了来自 154 名经活检证实的非酒精性脂肪性肝病患者的队列(西澳大利亚州尼德兰兹的查尔斯·盖尔德纳医院)。
我们证明,原代小鼠和人肝细胞在 NLRP3 炎性小体激活后可发生细胞焦亡,随后释放 NLRP3 炎性小体蛋白,放大和维持炎性小体驱动的纤维发生。细胞焦亡可通过阻断半胱天冬酶-1 和 Gasdermin D 的激活来抑制。在非酒精性脂肪性肝炎患者的肝脏和血清中检测到活化形式的半胱天冬酶-1,其与疾病严重程度相关。在正常饲料下,Nlrp3CreA 小鼠自发发生肝纤维化,并且在用低剂量脂多糖治疗后对肝损伤和炎症的敏感性增加。在机制上,肝星状细胞吞噬细胞外 NLRP3 炎性小体颗粒,导致 IL-1β 分泌和 α-平滑肌肌动蛋白表达增加。当细胞用胞吞抑制剂细胞松弛素 B 预处理时,这种作用被阻断。
这些结果确定了肝细胞焦亡和炎性小体成分的释放是促进肝损伤和肝纤维化发展的新机制。
我们的发现确定了肝脏炎症的一种新机制。细胞培养、小鼠和人类样本中的实验表明,一种称为细胞焦亡的特定细胞死亡形式导致 NLRP3 炎性小体等复杂炎症颗粒从肝细胞内释放到细胞外空间。从那里,它们被其他细胞摄取,并由此介导炎症和促纤维化应激信号。这种机制的发现可能为未来的慢性肝病治疗带来新的方法。